879.75
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Mckesson Corporation stock is traded at $879.75, with a volume of 669.36K.
It is down -0.25% in the last 24 hours and down -8.67% over the past month.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$881.94
Open:
$881.33
24h Volume:
669.36K
Relative Volume:
0.93
Market Cap:
$107.76B
Revenue:
$397.96B
Net Income/Loss:
$4.55B
P/E Ratio:
25.31
EPS:
34.7654
Net Cash Flow:
$9.64B
1W Performance:
-4.41%
1M Performance:
-8.67%
6M Performance:
+19.45%
1Y Performance:
+32.57%
Mckesson Corporation Stock (MCK) Company Profile
Name
Mckesson Corporation
Sector
Industry
Phone
972-446-4800
Address
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK vs COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MCK
Mckesson Corporation
|
879.75 | 108.03B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
325.08 | 63.66B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
CAH
Cardinal Health Inc
|
211.31 | 48.76B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
74.25 | 8.49B | 13.18B | 419.00M | 521.00M | 3.2704 |
|
AHG
Akso Health Group Adr
|
2.3693 | 1.94B | 14.85M | -136.07M | 7.23M | -0.4726 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Dec-04-24 | Resumed | Mizuho | Neutral |
| Nov-07-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-05-24 | Reiterated | Leerink Partners | Outperform |
| Aug-08-24 | Reiterated | Mizuho | Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jul-06-22 | Downgrade | Argus | Buy → Hold |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-02-21 | Reiterated | Barclays | Overweight |
| Nov-02-21 | Reiterated | BofA Securities | Buy |
| Nov-02-21 | Reiterated | Evercore ISI | Outperform |
| Nov-02-21 | Reiterated | Jefferies | Buy |
| Mar-30-21 | Upgrade | Argus | Hold → Buy |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
| May-22-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-18-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-13-20 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-10-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-05-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-22-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Jul-20-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-29-18 | Reiterated | Leerink Partners | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-02-18 | Reiterated | Mizuho | Neutral |
| Jan-24-18 | Upgrade | Jefferies | Hold → Buy |
View All
Mckesson Corporation Stock (MCK) Latest News
McKesson Accuses Former Exec. Of Leaking Trade Secrets - Law360
McKesson Corporation stock sees institutional interest as Pensionfund Sabic initiates position amid - AD HOC NEWS
2,300 Shares in McKesson Corporation $MCK Bought by Pensionfund Sabic - MarketBeat
A Look Back at Healthcare Providers & Services Stocks’ Q4 Earnings: McKesson (NYSE:MCK) Vs The Rest Of The Pack - FinancialContent
McKesson Corporation stock faces margin pressure amid opioid settlement costs and distribution shift - AD HOC NEWS
McKesson Corp. Stock Hits Day Low of $877.30 Amid Price Pressure - Markets Mojo
McKesson Advances Wound Care Solutions with New B2B and Homecare Innovations in 2026 - AD HOC NEWS
Cardinal Health vs. McKesson: Which Healthcare Giant Is the Smarter Bet? - The Globe and Mail
McKesson Corporation $MCK Shares Purchased by SG Americas Securities LLC - MarketBeat
Murphy Middleton Hinkle & Parker Inc. Acquires 115,480 Shares of McKesson Corporation $MCK - MarketBeat
McKesson Corporation $MCK Shares Sold by Assenagon Asset Management S.A. - MarketBeat
5-Day Sell-Off Sends McKesson Stock Down -7% - Trefis
McKesson Stock 5-Day Losing Spree: Stock Falls 7.0% - Trefis
McKesson stock price forecast for 2040: Oncology network and earnings growth drive $2,500 outlook - Traders Union
McKesson Corporation $MCK Shares Sold by Wealth Enhancement Advisory Services LLC - MarketBeat
Legacy Private Trust Co. Has $9.63 Million Holdings in McKesson Corporation $MCK - MarketBeat
Nordea Investment Management AB Has $885.25 Million Stock Holdings in McKesson Corporation $MCK - MarketBeat
Maridea Wealth Management LLC Increases Stake in McKesson Corporation $MCK - MarketBeat
Procyon Advisors LLC Increases Holdings in McKesson Corporation $MCK - MarketBeat
McKesson Corporation stock upgraded to Buy by Wall Street Zen amid recent pullback - AD HOC NEWS
McKesson Corporation (NYSE:MCK) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
McKesson (NYSE:MCK) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Is It Time To Reassess McKesson (MCK) After Recent Pullback And DCF Valuation Gap - simplywall.st
McKesson Corp. stock outperforms competitors despite losses on the day - MarketWatch
Here's Why You Should Add McKesson Stock to Your Portfolio Now - The Globe and Mail
Here’s Why Investing in McKesson Shares Is a Smart Move for Your Portfolio Today - Bitget
McKesson Corporation $MCK Shares Sold by Park National Corp OH - MarketBeat
CIBC Bancorp USA Inc. Acquires Shares of 17,187 McKesson Corporation $MCK - MarketBeat
McKesson Corporation opens registration for ideaShare 2026 to unite pharmacy professionals - Traders Union
News | McKesson to open major distribution hub on Montreal's east side - CoStar
McKesson Corp. stock underperforms Thursday when compared to competitors - MarketWatch
McKesson Corporation (MCK) latest stock news and headlines - Yahoo Finance Singapore
McKesson ideaShare 2026 Invites Independent Pharmacists to Learn, Connect and Grow - Yahoo Finance
Baird Adjusts Price Target on McKesson to $1,010 From $974, Maintains Outperform Rating - marketscreener.com
Mainstay Capital Management LLC ADV Sells 4,054 Shares of McKesson Corporation $MCK - MarketBeat
McKesson Corporation $MCK is Lynwood Price Capital Management LP's 3rd Largest Position - MarketBeat
Investment Research Partners LLC Makes New Investment in McKesson Corporation $MCK - MarketBeat
McKesson Corporation Stock (ISIN: US58155Q1031) Pulls Back Amid Strong Earnings and Bullish Analyst - AD HOC NEWS
McKesson Stock Falls 2.33 as 0.82 Billion Trading Volume Ranks 147th on March 19 - Bitget
Assessing McKesson (MCK) Valuation After Recent Share Pullback And Ongoing Growth Momentum - simplywall.st
McKesson Encounters Major Challenge: Will It Validate a 36.5% DCF Discount Despite Earnings Shortfalls and Strategic Changes? - Bitget
McKesson (MCK) Receives a Buy from Barclays - The Globe and Mail
McKesson Launches Advanced Wound Care Portfolio Expansion with New B2B and Homecare Solutions Drivin - AD HOC NEWS
The Zacks Analyst Blog Highlights GE Aerospace, Shell, McKesson, Elite Pharmaceuticals and Geospace Technologies - Zacks Investment Research
McKesson (MCK): A Deep-Dive into the Backbone of the Healthcare Supply Chain - FinancialContent
McKesson Corp (NYSE:MCK) Presents a Compelling Growth at a Reasonable Price (GARP) Case - ChartMill
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Danske Bank A S Invests $127.49 Million in McKesson Corporation $MCK - MarketBeat
Danica Pension Livsforsikringsaktieselskab Buys $135M Stake in McKesson - National Today
175,204 Shares in McKesson Corporation $MCK Bought by Danica Pension Livsforsikringsaktieselskab - MarketBeat
ARQ Wealth Advisors LLC Takes Position in McKesson Corporation $MCK - MarketBeat
Mckesson Corporation Stock (MCK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):